Specific deletion of ST2 in Treg cells enables CD8-mediated killing of AML cells by sequestering ST2+ Treg cells precursors in the lymph nodes and regulating their transcriptional signatures, and inhibiting Treg cells’ cytotoxicity towards CD8 T cells. This evidence concerns the gene CD8A and acute myeloid leukemia.